Physician profile
Allen Eugene Priest
NPI 1487724704
$3,055.05
in general payments reported to CMS, 2019-2025
15 companies · $63.68 in 2025
The $63.68 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,644 · 2020: $102 · 2021: $368 · 2022: $676 · 2023: $91.65 · 2024: $110 · 2025: $63.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $549.96 | 2019-2025 | Collagenase Santyl, Regranex |
| Astrazeneca Pharmaceuticals LP | $526.85 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $520.86 | 2019-2022 | |
| Novo Nordisk INC | $383.95 | 2019-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $238.36 | 2019-2021 | |
| Glaxosmithkline, LLC. | $228.24 | 2019-2022 | |
| Medtronic Vascular, INC. | $132.26 | 2019 | |
| Cardiovascular Systems INC. | $111.12 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $94.19 | 2021 | |
| Abbvie INC. | $66.33 | 2022-2024 | |
| Pfizer INC. | $64.32 | 2020-2025 | |
| Amgen INC. | $50.12 | 2019-2023 | Prolia, Evenity |
| Exact Sciences Corporation | $37.44 | 2023-2024 | Cologuard Collection Kit |
| Bausch Health US, LLC | $31.71 | 2021 | |
| Arbor Pharmaceuticals, INC. | $19.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Priest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.